Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Presentations

Update on SAVAL Tibial Stent Trial

International Symposium on Endovascular Therapy 2020

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Intravascular Lithotripsy
FastWave Medical Extends Intellectual Property Portfolio With the Issuance of Its Utility Patent for Novel Laser-IVL Technology
04/16/2024

FastWave Medical Inc. News

FastWave Medical Inc. News
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has enormous potential to leapfrog today's IVL technology with durable, fast, and consistent laser energy," says Dr. William Nicholson. "It also enables FastWave's team of engineers to develop an ultra-sleek balloon...
"FastWave's novel approach has...
04/16/2024
Cath Lab Digest
PerQseal Elite Vascular Closure System
Venous Closure
Vivasure Medical Announces First Large Hole Venous Patient Treated With PerQseal Elite Vascular Closure System
04/15/2024

Vivasure Medical News

Vivasure Medical News
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced it has treated the first large bore venous patient with the PerQseal® Elite vascular closure system, a sutureless and fully...
Vivasure Medical, a company...
04/15/2024
Cath Lab Digest
Lower-extremity intervention
Revascularization Enhances Quality of Life for Patients With Chronic Limb-Threatening Ischemia
04/10/2024

Brigham and Women's Hospital / Boston Medical Center News

Brigham and Women's Hospital / Boston...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that patients with CLTI have a notably poor quality of life – substantially lower than with many other chronic conditions,” said Matthew Menard, MD. “Our findings show that revascularization significantly improves quality...
“Our study indicates that...
04/10/2024
Cath Lab Digest
aorto-iliac occlusive disease
Getinge iCast Covered Stent System Considered Medically Necessary for Treatment of Iliac Arterial Occlusive Disease
04/09/2024

Getinge News

Getinge News
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a leading health insurance benefits company in the United States, issued a Clinical Policy Bulletin (CPB) addressing peripheral vascular stents. Aetna issued a revised CPB stating that the iCast covered stent...
Getinge announced Aetna, a...
04/09/2024
Cath Lab Digest
Hypertension
ACC.24: SPYRAL HTN Clinical Program Data Show Durability of Medtronic Renal Denervation System
04/08/2024

Medtronic News

Medtronic News
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Long-term durability data showed clinically meaningful, safe and sustained blood pressure (BP) reductions (-23.2 mmHg in office systolic BP and -14.0 mmHg reductions in 24-hour ambulatory BP) in patients with uncontrolled hypertension.
Long-term durability data...
04/08/2024
Cath Lab Digest
aorto-iliac occlusive disease
First Patient Enrolled in Clinical Study for CERAB With Bentley Covered Stents
04/07/2024

Bentley News

Bentley News
The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is...
The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is...
The CERAB technique (covered...
04/07/2024
Cath Lab Digest
Amputation Prevention
EHRA 24: Electronic Sock Detects Unhealthy Walking Style Linked With Diabetes and Poor Circulation
04/07/2024

European Heart Rhythm Association (EHRA) News

European Heart Rhythm Association (EH...
Study author Dr. Ki Hong Lee of Chonnam National University Hospital, Gwangju, Republic of Korea said: “Patients with diabetes tend to put pressure on the metatarsal area of the foot, rather than the heel. This way of walking encourages...
Study author Dr. Ki Hong Lee of Chonnam National University Hospital, Gwangju, Republic of Korea said: “Patients with diabetes tend to put pressure on the metatarsal area of the foot, rather than the heel. This way of walking encourages...
Study author Dr. Ki Hong Lee of...
04/07/2024
Cath Lab Digest
Intravascular Lithotripsy
Johnson & Johnson to Acquire Shockwave Medical
04/05/2024

Johnson & Johnson and Shockwave Medical, Inc. News

Johnson & Johnson and Shockwave M...
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an...
Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an...
Johnson & Johnson and Shockwave...
04/05/2024
Cath Lab Digest
News
Register Now for the 25th Annual New Cardiovascular Horizons Conference in New Orleans
04/05/2024

New Cardiovascular Horizons News

New Cardiovascular Horizons News ...
Join us for a Comprehensive Review of Cardiovascular Medicine to 20+ CMEs NEW ORLEANS –Bringing physicians from around the world together for a comprehensive review of cardiovascular medicine, the 25th annual New Cardiovascular Horizons...
Join us for a Comprehensive Review of Cardiovascular Medicine to 20+ CMEs NEW ORLEANS –Bringing physicians from around the world together for a comprehensive review of cardiovascular medicine, the 25th annual New Cardiovascular Horizons...
Join us for a Comprehensive...
04/05/2024
Vascular Disease Management
News
Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
04/05/2024

Clarius Mobile Health News

Clarius Mobile Health News
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission VANCOUVER, BC, April 5, 2024 /PRNewswire/ -- Clarius Mobile Health,...
Having achieved CE Mark for...
04/05/2024
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement